|Videos|November 28, 2022
Exploring Recent Updates in the Treatment of Breast Cancer
On September 14, 2022, William Gradishar, MD moderated a virtual workshop with fellow oncologists to discuss best practices for biomarker testing, the emerging concept of HER2-low BC, and treatment approaches for BC throughout the course of the disease. This article summarizes key takeaways and stakeholder insights from this workshop.
Advertisement
Advertisement
Latest CME
Advertisement
Advertisement
Trending on OncLive
1
FDA Accepts NDA for Zanzalintinib Plus Atezolizumab in Pretreated mCRC
2
Retrospective, Real-World Analysis Shows Improved OS With Apalutamide Over Darolutamide in mCSPC
3
HPV Vaccination and Evolving Screening Strategies Continue to Shape Cervical Cancer Prevention Efforts
4
SC Daratumumab Plus VRd Expands Options in Newly Diagnosed, Transplant-Ineligible Myeloma
5
































